1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders


2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome


3. Executive Summary
3.1. Market Outlook
3.2. Technology Outlook
3.3. Application Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook


4. Market Overview
4.1. Introduction


5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges


6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations


7. Global Transcriptomics Technologies Market, By Technology
7.1. Introduction
7.2. Gene Regulation Technologies
7.3. Microarray
7.4. Next Generation Sequencing
7.5. PCR


8. Global Transcriptomics Technologies Market, By Application
8.1. Introduction
8.2. Bioinformatics
8.3. Clinical Diagnostics
8.4. Comparative Transcriptomics
8.5. Drug Discovery & Research


9. Global Transcriptomics Technologies Market, By End User
9.1. Introduction
9.2. Academic Research
9.3. Pharmaceutical & Biotech Companies


10. Global Transcriptomics Technologies Market, By Geography
10.1. Introduction
10.2. Americas
10.2.1. Argentina
10.2.2. Brazil
10.2.3. Canada
10.2.4. Mexico
10.2.5. United States
10.3. Asia-Pacific
10.3.1. Australia
10.3.2. China
10.3.3. India
10.3.4. Indonesia
10.3.5. Japan
10.3.6. Malaysia
10.3.7. Philippines
10.3.8. South Korea
10.3.9. Thailand
10.4. Europe, Middle East & Africa
10.4.1. France
10.4.2. Germany
10.4.3. Italy
10.4.4. Netherlands
10.4.5. Qatar
10.4.6. Russia
10.4.7. Saudi Arabia
10.4.8. South Africa
10.4.9. Spain
10.4.10. United Arab Emirates
10.4.11. United Kingdom


11. 360iResearch Competitive Strategic Window
11.1. Introduction
11.2. 360iResearch Competitive Strategic Window, by Technology
11.3. 360iResearch Competitive Strategic Window, by Application
11.4. 360iResearch Competitive Strategic Window, by End User
11.5. 360iResearch Competitive Strategic Window, by Geography


12. Competitive Landscape
12.1. 360iResearch FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. 360iResearch Market Ranking Analysis
12.3. 360iResearch Market Share Analysis
12.4. 360iResearch Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion


13. Company Usability Profiles
13.1. Agilent Technologies Inc.
13.2. Bio-Rad Laboratories
13.3. Danaher Corporation
13.4. F. Hoffmann La Roche Ltd
13.5. Fluidigm Corporation
13.6. Illumina Inc.
13.7. Life Technologies Corporation
13.8. Qiagen N. V.
13.9. Sigma Aldrich Corporation
13.10. Thermo Fisher Scientific


14. Appendix
14.1. Discussion Guide
14.2. Edition Details
14.3. License Details
14.4. Pricing Details